Open AccessJournal Article
Long-term survival.
Cho Yw,Terasaki Pi +1 more
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.Abstract:
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.read more
Citations
More filters
Journal ArticleDOI
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
Michael J. Lind,B. M. J. Cantwell,Michael Millward,A. Robinson,Mark R. Proctor,D. Simmons,Joseph C. Carmichael,Al Harris +7 more
TL;DR: The use of goserelin in patients with epithelial ovarian cancers resistant to or relapsing soon after first line platinum based chemotherapy needs to be further evaluated.
Journal ArticleDOI
Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea
Barbara E. Wildhaber,Barbara E. Wildhaber,Felix Niggli,Eva Bergsträsser,Thomas Stallmach,Peter Sacher +5 more
TL;DR: Either severe diarrhoea or chronic constipation may represent rare paraneoplastic syndromes in ganglioneuroblastomas.
BookDOI
Apoptosis: Mechanisms and Role in Disease
TL;DR: T Cell Apoptosis in HIV Infection: Mechanism and Relevance for AIDS Pathogenesis and the Point of No Return.
Prognostic factors of long-term allograft survival in 632 CyA-treated recipients of
Giuseppe Montagnino,Antonio Tarantino,Bruno Mario Cesana,Giuseppe Rossini,Isabella Da Milano,Adriana Arodi,A. Elli,C. Ponticelli +7 more
TL;DR: It would appear that the initial lesions in primary renal allograft recipients are induced by events mostly mediated by immunological mechanisms, and young patients did worse not because of steroid withdrawal, but because of inadequate initial CyA dosage.
Journal ArticleDOI
Predicting respiratory infection one year after inpatient rehabilitation with pulmonary function measured at discharge in persons with spinal cord injury.
Karin Postma,Johannes B. J. Bussmann,Janneke A. Haisma,van der Lucas Woude,Michael P. Bergen,Henk J. Stam +5 more
TL;DR: Pulmonary function at discharge from inpatient rehabilitation can be used as a predictor of respiratory infection in the first year after discharge in spinal cord injury; only percentage predicted forced vital capacity was less accurate.